Notably, the National Institutes of Health (NIH) mutation database (URL: https://portal.gdc.cancer.gov/) includes TSC patients who carry mutations at arginine residues, including in R1457 and R1459 of TSC2, suggesting that these sites do have physiological relevance for TSC pathology. The gene discussed is TSC2; the disease is tuberous sclerosis.